PFS
STRO icon

Prospera Financial Services’s Sutro Biopharma STRO Stock Holding History

Prospera Financial Services’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-610
Closed -$50K – 2499
2022
Q1 		$50K Buy
+610
New +$58K ﹤0.01% 1383
2020
Q4 		– Sell
-552
Closed -$56K – 1458
2020
Q3 		$56K Buy
+552
New +$52.2K 0.02% 582

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Prospera Financial Services's STRO Position: Q2 2022 in Review

Prospera Financial Services sold out of Sutro Biopharma (STRO) in Q2 2022, closing a stake of 610 shares — an estimated $50K sold.

Prospera Financial Services first reported a position in STRO in Q3 2020 and held it in 2 quarters. The position peaked at $56K in Q3 2020. 114 funds tracked by Wall St. Rank hold STRO as of Q2 2022.

  • Prospera Financial Services reported no remaining Sutro Biopharma position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 610 Sutro Biopharma shares in Q2 2022, an estimated $50K.
  • Prospera Financial Services first reported a position in Sutro Biopharma in Q3 2020 and held it in 2 quarters.
  • Prospera Financial Services's Sutro Biopharma position peaked at $56K in Q3 2020.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.